Insider Selling: AMERISAFE (NASDAQ:AMSF) CFO Sells 1,247 Shares of Stock

AMERISAFE, Inc. (NASDAQ:AMSF) CFO Anastasios Omiridis sold 1,247 shares of the firm’s stock in a transaction that occurred on Thursday, November 20th. The stock was sold at an average price of $40.21, for a total transaction of $50,141.87. Following the sale, the chief financial officer directly owned 2,539 shares of the company’s stock, valued at approximately $102,093.19. The trade was a 32.94% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.

AMERISAFE Price Performance

Shares of AMSF traded up $0.23 on Thursday, hitting $40.58. The company’s stock had a trading volume of 112,046 shares, compared to its average volume of 110,377. The company has a market capitalization of $767.94 million, a PE ratio of 15.55 and a beta of 0.33. AMERISAFE, Inc. has a fifty-two week low of $39.09 and a fifty-two week high of $59.51. The company has a 50 day moving average price of $41.96 and a 200 day moving average price of $44.22.

AMERISAFE (NASDAQ:AMSF) last released its quarterly earnings results on Wednesday, October 29th. The insurance provider reported $0.55 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.55. AMERISAFE had a return on equity of 17.16% and a net margin of 16.12%.The firm had revenue of $71.29 million during the quarter, compared to analysts’ expectations of $78.29 million. On average, equities analysts forecast that AMERISAFE, Inc. will post 2.45 EPS for the current year.

AMERISAFE Announces Dividend

The firm also recently announced a special dividend, which will be paid on Friday, December 12th. Stockholders of record on Friday, December 5th will be paid a $1.00 dividend. The ex-dividend date is Friday, December 5th. This represents a dividend yield of 394.0%. AMERISAFE’s dividend payout ratio (DPR) is 59.77%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on the stock. Citigroup reissued a “market outperform” rating on shares of AMERISAFE in a report on Thursday, October 30th. Weiss Ratings reissued a “hold (c-)” rating on shares of AMERISAFE in a research note on Monday. Truist Financial lowered their price target on shares of AMERISAFE from $54.00 to $50.00 and set a “hold” rating for the company in a report on Monday, July 28th. JMP Securities decreased their price objective on AMERISAFE from $65.00 to $60.00 and set a “market outperform” rating on the stock in a research report on Tuesday, October 14th. Finally, Wall Street Zen cut AMERISAFE from a “hold” rating to a “sell” rating in a research note on Saturday, November 8th. Two analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $55.00.

Hedge Funds Weigh In On AMERISAFE

Large investors have recently bought and sold shares of the business. Signaturefd LLC boosted its stake in AMERISAFE by 170.5% in the second quarter. Signaturefd LLC now owns 779 shares of the insurance provider’s stock valued at $34,000 after acquiring an additional 491 shares during the last quarter. Quarry LP grew its stake in shares of AMERISAFE by 346.9% during the third quarter. Quarry LP now owns 943 shares of the insurance provider’s stock worth $41,000 after purchasing an additional 732 shares during the period. PNC Financial Services Group Inc. increased its holdings in AMERISAFE by 301.6% in the first quarter. PNC Financial Services Group Inc. now owns 1,554 shares of the insurance provider’s stock valued at $82,000 after purchasing an additional 1,167 shares during the last quarter. GAMMA Investing LLC increased its holdings in AMERISAFE by 38.6% in the third quarter. GAMMA Investing LLC now owns 1,633 shares of the insurance provider’s stock valued at $72,000 after purchasing an additional 455 shares during the last quarter. Finally, Tower Research Capital LLC TRC lifted its stake in AMERISAFE by 87.9% in the second quarter. Tower Research Capital LLC TRC now owns 1,920 shares of the insurance provider’s stock valued at $84,000 after buying an additional 898 shares during the period. 97.41% of the stock is currently owned by institutional investors and hedge funds.

About AMERISAFE

AMERISAFE, Inc, an insurance holding company, underwrites workers’ compensation insurance in the United States. The company provides benefits to injured employees for temporary or permanent disability, death, and medical and hospital expenses. It sells its products through retail and wholesale brokers and agents; and small and mid-sized employers engaged in hazardous industries, including construction, trucking, logging and lumber, agriculture, manufacturing, telecommunications, and maritime.